Form 4: Medicine Man Technologies Director Jeffrey Cozad Receives Stock Grant for Board Service
SEC Form 4 Filing
Director Jeffrey Cozad received 33,537 shares of Medicine Man Technologies common stock as compensation for board service.
Summary
- Jeffrey Cozad, a director of Medicine Man Technologies, Inc. (SHWZ), received 33,537 shares of common stock on March 29, 2024, as compensation for his service on the board.
- The shares were granted at a price of $0, reflecting their issuance as part of his compensation.
- Following the transaction, Cozad directly owns 251,618 shares of Medicine Man Technologies.
- A power of attorney was executed on April 2, 2024, granting Philip McDermott, Christine Jones, and Zachary Weiss the authority to act on Cozad's behalf in matters related to SEC filings.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing indicating standard compensation practices. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Positives
- The stock grant aligns the director's interests with those of the shareholders.
- The power of attorney ensures compliance with SEC regulations.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It reflects compensation practices for board members in the cannabis industry.
Comparison to Industry Standards
- Stock grants are a common form of compensation for directors in publicly traded companies, including those in the cannabis industry.
- Comparing the size of the grant to those of directors at similar companies like Curaleaf, Trulieve, or Green Thumb Industries would provide context on whether this grant is standard or exceptional.
Stakeholder Impact
- The stock grant could have a minor dilutive effect on existing shareholders.
- The grant incentivizes the director to act in the best interests of the company and its shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date used to calculate the value of the stock grant based on the closing price of the common stock on the OTCQX Best Market. |
| 03/29/2024 | Date of the transaction where Jeffrey Cozad acquired 33,537 shares of common stock. |
| 04/02/2024 | Date of the Power of Attorney execution. |
Keywords
Medicine Man Technologies, Jeffrey Cozad, stock grant, director compensation, SEC Form 4, beneficial ownership, power of attorney, SHWZ
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.